Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
National Institutes of Health (NIH)
Total funding amount is approximately $4 million for fiscal year 2023.
Individual awards up to $500,000 for Phase I and $2.5 million for Phase II.
Support research that may lead to the development of innovative products and/or services for preventing and treating Alzheimer's disease and related dementias.
Small business concerns (SBCs) in the United States.
Individuals living with Alzheimer's disease and related dementias.
Reissue of PAS-19-317.
Aligned with agency priorities and recommendations from the National Alzheimer’s Project Act.
Funded by the National Institute on Aging (NIA) and National Institute of Neurological Disorders and Stroke (NINDS).
Type: Small Business Technology Transfer (STTR) Grant.
Addresses critical barriers in Alzheimer's disease research and aims to reduce healthcare costs.
Recurring grant opportunity with multiple application deadlines.
Only United States small business concerns (SBCs) are eligible.
Must be organized for profit and operate primarily within the United States.
Must have not more than 500 employees.
Must be located in the United States.
Must meet specific ownership and control criteria outlined in the grant.
Not specified.
Must be in a legal form such as corporation, partnership, or limited liability company.
Encourages research addressing disparities in care among diverse populations.
Not specified.
Not specified.
Research on prevention, diagnosis, treatment, and care for Alzheimer's disease and related dementias.
Healthcare, technology development.
Individuals living with AD/ADRD, healthcare providers, and small businesses.
Must be based in the United States.
Not specified.
Innovative products and services that advance progress in AD/ADRD.
Must align with NIA's strategic plan.
Reduction in human burden and healthcare costs associated with AD/ADRD.
Phase I and Phase II projects.
Not specified.
Not specified.
Not specified.
Must include a Program Director/Principal Investigator with relevant skills.
Must adhere to NIH-defined clinical trial standards if applicable.
Must comply with NIH grants policies.
Must follow SBIR/STTR application instructions.
Not specified.
Rights to data generated during the award retained for up to 20 years.
Not specified.
Not specified.
Must comply with data management and sharing policies.
Must comply with NIH Grants Policy Statement.
Phase I budgets up to $500,000; Phase II budgets up to $2.5 million.
Not specified.
Not specified.
Not specified.
Not specified.
Must comply with NIH reporting requirements.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Multiple deadlines: January 5, 2023; April 5, 2023; September 5, 2023; January 5, 2024; April 5, 2024; September 5, 2024; January 5, 2025; April 5, 2025; September 5, 2025.
Phase I: up to 2 years; Phase II: up to 3 years.
Applicants are encouraged to propose a reasonable project duration.
Annual reporting required.
Not specified.
Must comply with NIH monitoring requirements.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Must comply with NIH Grants Policy Statement.
Not specified.
Must comply with data management and sharing policies.
Not specified.
Must adhere to ethical standards in research.
Foreign institutions are not eligible to apply.
Not specified.
Not specified.
Not specified.
Must comply with NIH reporting requirements.
Not specified.
Must comply with federal regulations.
Must follow the SBIR/STTR application instructions.
Applications must be submitted electronically via Grants.gov.
Applications evaluated based on scientific and technical merit.
Applications undergo peer review and advisory council review.
Scientific merit and alignment with NIA priorities.
Not specified.
Must use Grants.gov or NIH ASSIST system.
Not specified.
Not specified.
eRA Service Desk available for assistance.
Resubmissions allowed for all phases.
Encourages research addressing disparities in care.
Not specified.
Aligns with NIA's strategic plan.
Not specified.
Focus on diversity and inclusion in research.
Encourages innovative approaches to AD/ADRD.
Must include a research component related to AD/ADRD.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.
Not specified.